Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02651883 · ClinicalTrials.gov registry record · NA
Effect of Human Papillomavirus Self-Collection on Cervical Cancer Screening in High Risk Women: My Body, My Test 3
A NA study, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 665
- Enrollment target
NCT02651883 is a NA study that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 665 participants.
The verdict
NCT02651883, a NA study, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 665 participants
- Enrollment target
Study Summary
This study will investigate whether cervical cancer screening completion among under-screened women could be improved by offering HPV (human papillomavirus) testing by at-home self-collection followed by screening invitation compared to screening invitation alone.
Interventions
- BEHAVIORAL Screening invitation (with education)
- BEHAVIORAL Self-collection for HPV testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 665 participants |
| Start Date | 2016-04 |
| Est. Completion | 2020-04-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02651883
The ClinicalTrials.gov registry entry for NCT02651883 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 665 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Screening invitation (with education) is the first listed.
NCT02651883 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02651883 about?
NCT02651883 is a clinical study titled "Effect of Human Papillomavirus Self-Collection on Cervical Cancer Screening in High Risk Women: My Body, My Test 3". This study will investigate whether cervical cancer screening completion among under-screened women could be improved by offering HPV (human papillomavirus) testing by at-home self-collection followed by screening invitation compared to screening invitation alone.
What is the current status of trial NCT02651883?
This trial is currently completed. It is a NA study. The enrollment target is 665 participants. The study started on 2016-04. Estimated completion is 2020-04-10.
What interventions are being tested in trial NCT02651883?
The interventions under investigation include: Screening invitation (with education) (BEHAVIORAL), Self-collection for HPV testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT02651883?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.